| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.3 | 3e-05 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.22 | 4e-05 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.89 | 0.0001 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.26 | 0.0003 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0006 |